Keywords: merck, serono, extends, erbitux, indication, pharmaceuticals, division

Merck Serono extends Erbitux indication

Article | 15 December 2008

Print This

Merck Serono, the pharmaceuticals division of Germany's Merck KGaA, has received approval from the European Commission to extend the use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in